Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Cancer Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Cancer Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Europe Bladder Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in non-invasive diagnostics
3.2.1.2. Shifting to a precision-based approach in NMIBC
3.2.1.3. Rising awareness for the early diagnosis of bladder cancer
3.2.2. Market restraint analysis
3.2.2.1. High cost associated with diagnosis and treatment of bladder cancer
3.3. Europe Bladder Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Europe Bladder Cancer Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Europe Bladder Cancer Diagnostics Market: Technology Movement Analysis
4.3. Europe Bladder Cancer Diagnostics Market Size & Trend Analysis, by diagnostic technique, 2018 to 2030 (USD Million)
4.4. Cystoscopy
4.4.1. Cystoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Ultrasound
4.5.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Urinalysis
4.6.1. Urinalysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Europe Bladder Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
5.1. Cancer Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Europe Bladder Cancer Diagnostics Market by Cancer Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Transitional Cell Bladder Cancer
5.5.1. Transitional Cell Bladder Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Squamous Cell Bladder Cancer
5.6.1. Squamous Cell Bladder Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Europe Bladder Cancer Diagnostics Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Europe Bladder Cancer Diagnostics Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospital Settings
6.5.1. Hospital Settings Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Non Hospital Settings
6.6.1. Non Hospital Settings Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Europe Bladder Cancer Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Country Market Share Analysis, 2023 & 2030
7.2. Country Market Dashboard
7.3. Country Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/Reimbursement
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/Reimbursement
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/Reimbursement
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/Reimbursement
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/Reimbursement
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/Reimbursement
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/Reimbursement
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework/Reimbursement
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5.9. Poland
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework/Reimbursement
7.5.9.3. Competitive scenario
7.5.9.4. Poland market estimates and forecasts 2018 to 2030 (USD Million)
7.5.10. Finland
7.5.10.1. Key country dynamics
7.5.10.2. Regulatory framework/Reimbursement
7.5.10.3. Competitive scenario
7.5.10.4. Finland market estimates and forecasts 2018 to 2030 (USD Million)
7.5.11. Estonia
7.5.11.1. Key country dynamics
7.5.11.2. Regulatory framework/Reimbursement
7.5.11.3. Competitive scenario
7.5.11.4. Estonia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.12. Latvia
7.5.12.1. Key country dynamics
7.5.12.2. Regulatory framework/Reimbursement
7.5.12.3. Competitive scenario
7.5.12.4. Latvia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.13. Latvia
7.5.13.1. Key country dynamics
7.5.13.2. Regulatory framework/Reimbursement
7.5.13.3. Competitive scenario
7.5.13.4. Latvia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.14. Lithuania
7.5.14.1. Key country dynamics
7.5.14.2. Regulatory framework/Reimbursement
7.5.14.3. Competitive scenario
7.5.14.4. Lithuania market estimates and forecasts 2018 to 2030 (USD Million)
7.5.15. Portugal
7.5.15.1. Key country dynamics
7.5.15.2. Regulatory framework/Reimbursement
7.5.15.3. Competitive scenario
7.5.15.4. Portugal market estimates and forecasts 2018 to 2030 (USD Million)
7.5.16. The Netherlands
7.5.16.1. Key country dynamics
7.5.16.2. Regulatory framework/Reimbursement
7.5.16.3. Competitive scenario
7.5.16.4. The Netherlands market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Abbott
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Services benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Nucleix
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Services benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Danaher Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Services benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Pacific Edge
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Services benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Polymedco, LLC.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Services benchmarking
8.3.8.4. Strategic initiatives
8.3.9. KARL STORZ
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Services benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AroCell (IDL Biotech)
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Services benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Micromedic Technologies
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Services benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Sysmex Corporation
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Services benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Vesica Health
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Services benchmarking
8.3.13.4. Strategic initiatives



List of Figures

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Europe
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe bladder cancer diagnostics market: market outlook
Fig. 10 Europe bladder cancer diagnostics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Europe bladder cancer diagnostics market driver impact
Fig. 16 Europe bladder cancer diagnostics market restraint impact
Fig. 17 Europe bladder cancer diagnostics market strategic initiatives analysis
Fig. 18 Europe bladder cancer diagnostics market: Technology movement analysis
Fig. 19 Europe bladder cancer diagnostics market: Technology outlook and key takeaways
Fig. 20 Cystoscopy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 CSF Cystoscopy estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Blood based Cystoscopy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Ultrasound estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Urinalysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Europe bladder cancer diagnostics Market: Cancer type movement analysis
Fig. 27 Europe bladder cancer diagnostics market: Cancer type outlook and key takeaways
Fig. 28 Transitional Cell Bladder Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Squamous Cell Bladder Cancer market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 31 Europe bladder cancer diagnostics market: End-user movement analysis
Fig. 32 Europe bladder cancer diagnostics market: End-user outlook and key takeaways
Fig. 33 Hospital Settings market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Non Hospital Settings market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 35 Europe bladder cancer diagnostics market: Regional movement analysis
Fig. 36 Europe bladder cancer diagnostics market: Regional outlook and key takeaways
Fig. 37 Europe bladder cancer diagnostics market share and leading players
Fig. 38 Europe market share and leading players
Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Finland market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Poland market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Estonia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Lithuania market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Latvia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Latvia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Portugal market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 The Netherlands market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Market share of key market players- Europe bladder cancer diagnostics market

List of Tables

List of Tables

Table 1 List of abbreviations
Table 2 Europe bladder cancer diagnostics market, by country, 2018 - 2030 (USD Million)
Table 3 Europe bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 4 Europe bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 5 Europe bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 6 Germany bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 7 Germany bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 8 Germany bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 UK bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 10 UK bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 11 UK bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 12 France bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 13 France bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 14 France bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 15 Italy bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 16 Italy bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 17 Italy bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 Spain bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 19 Spain bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 20 Spain bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 21 Denmark bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 22 Denmark bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 23 Denmark bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Sweden bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 25 Sweden bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 26 Sweden bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 27 Norway bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 28 Norway bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 29 Norway bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Finland bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 31 Finland bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 32 Finland bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 Poland bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 34 Poland bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 35 Poland bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 36 Estonia bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 37 Estonia bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 38 Estonia bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 Latvia bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 40 Latvia bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 41 Latvia bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 42 Latvia bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 43 Latvia bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 44 Latvia bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Lithuania bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 46 Lithuania bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 47 Lithuania bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 48 Portugal bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 49 Portugal bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 50 Portugal bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 51 The Netherlands bladder cancer diagnostics market, by technology, 2018 - 2030 (USD Million)
Table 52 The Netherlands bladder cancer diagnostics market, by cancer type, 2018 - 2030 (USD Million)
Table 53 The Netherlands bladder cancer diagnostics market, by end use, 2018 - 2030 (USD Million)